ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,570Medicare Part D Prescriptions Filled, Including Refills

Rank: 121 out of 1111

$766K Total Retail Price of All Prescriptions

Rank: 82 out of 1111

449 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
54% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 449 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

24% of this provider’s 449 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Risky Drugs to Seniors

2% of this provider’s 8,945 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$66 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
HYDROCODONE-ACETAMINOPHEN 511 345 S3 1 1
OMEPRAZOLE 450 340 2 4
SIMVASTATIN 427 366 3 5
POTASSIUM CHLORIDE 271 253 4 9
FUROSEMIDE 257 245 5 6
LEVOTHYROXINE SODIUM 242 208 6 3
GABAPENTIN 235 184 7 10
CARVEDILOL 234 192 8 21
ATORVASTATIN CALCIUM 209 174 9 15
TRAMADOL HCL 197 144 10 13
PRAVASTATIN SODIUM 174 123 11 17
PAROXETINE HCL 168 146 12 55
METFORMIN HCL 167 112 13 8
DONEPEZIL HCL 162 162 14 25
CRESTOR 160 132 15 33
MELOXICAM 151 88 16 18
NAMENDA 148 148 17 31
WARFARIN SODIUM 145 140 18 19
LISINOPRIL 143 123 19 2
ALENDRONATE SODIUM 142 125 20 35
FLUTICASONE PROPIONATE 141 118 21 27
ZOLPIDEM TARTRATE 138 94 22 16
SERTRALINE HCL 137 90 23 24
AMLODIPINE BESYLATE 135 103 24 7
GLIMEPIRIDE 115 107 25 61
HYDROCHLOROTHIAZIDE 107 64 26 11
RANITIDINE HCL 106 97 27 29
LOSARTAN-HYDROCHLOROTHIAZIDE 104 75 28 72
METOPROLOL SUCCINATE 102 87 29 20
CHLORTHALIDONE 94 78 30 193
METFORMIN HCL ER 91 73 31 84
NEXIUM 88 69 32 26
CELEBREX 85 59 33 81
CLONIDINE HCL 85 38 33 42
ATENOLOL 82 59 35 22
ATENOLOL-CHLORTHALIDONE 82 71 35 222
CLOPIDOGREL 81 75 37 30
METOPROLOL TARTRATE 79 74 38 12
PLAVIX 78 68 39 49
LISINOPRIL-HYDROCHLOROTHIAZIDE 78 65 39 23
CYMBALTA 77 47 41 40
SPIRIVA 73 44 42 53
ENALAPRIL MALEATE 69 50 43 56
ALLOPURINOL 63 33 44 36
SPIRONOLACTONE 61 43 45 83
CITALOPRAM HBR 61 52 45 14
OXYBUTYNIN CHLORIDE 61 44 45 110
LANTUS 60 36 48 46
QUINAPRIL HCL 59 56 49 213
VENTOLIN HFA 59 32 49 122
ADVAIR DISKUS 58 33 51 43
ESTRADIOL 57 31 R 52 102
TAMSULOSIN HCL 57 41 52 28
TIZANIDINE HCL 56 32 54 91
ISOSORBIDE MONONITRATE ER 56 49 54 73
DIGOXIN 54 37 56 47
LOSARTAN POTASSIUM 52 43 57 34
NAPROXEN 52 40 57 85
DOXYCYCLINE HYCLATE 50 40 59 113
RISPERIDONE 50 42 59 60
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 1, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.